BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 11034239)

  • 1. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?
    Klauber-DeMore N; Tan LK; Liberman L; Kaptain S; Fey J; Borgen P; Heerdt A; Montgomery L; Paglia M; Petrek JA; Cody HS; Van Zee KJ
    Ann Surg Oncol; 2000 Oct; 7(9):636-42. PubMed ID: 11034239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of sentinel lymph node biopsy in ductal carcinoma in situ (DCIS) and DCIS with microinvasion of the breast.
    van la Parra RF; Ernst MF; Barneveld PC; Broekman JM; Rutten MJ; Bosscha K
    Eur J Surg Oncol; 2008 Jun; 34(6):631-5. PubMed ID: 17851019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
    Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
    J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of patients with ductal carcinoma in situ and sentinel node biopsy.
    Meretoja TJ; Heikkilä PS; Salmenkivi K; Leidenius MH
    Ann Surg Oncol; 2012 Jul; 19(7):2345-51. PubMed ID: 22395995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node biopsy for ductal carcinoma in situ: an evolving approach at the University of Florida.
    Camp R; Feezor R; Kasraeian A; Cendan J; Schell S; Wilkinson E; Copeland E; Lind S
    Breast J; 2005; 11(6):394-7. PubMed ID: 16297082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ductal carcinoma in situ with microinvasion: prognostic implications, long-term outcomes, and role of axillary evaluation.
    Parikh RR; Haffty BG; Lannin D; Moran MS
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):7-13. PubMed ID: 20950955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update of sentinel lymph node mapping in patients with ductal carcinoma in situ.
    Wilkie C; White L; Dupont E; Cantor A; Cox CE
    Am J Surg; 2005 Oct; 190(4):563-6. PubMed ID: 16164920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?
    Cox CE; Nguyen K; Gray RJ; Salud C; Ku NN; Dupont E; Hutson L; Peltz E; Whitehead G; Reintgen D; Cantor A
    Am Surg; 2001 Jun; 67(6):513-9; discussion 519-21. PubMed ID: 11409797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
    Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ
    Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective approach to radionuclide-guided sentinel lymph node biopsy in high-risk ductal carcinoma in situ of the breast.
    Usmani S; Khan HA; Al Saleh N; abu Huda F; Marafi F; Amanguno HG; Al Nafisi N; Al Kandari F
    Nucl Med Commun; 2011 Nov; 32(11):1084-7. PubMed ID: 21862942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor size as predictor of microinvasion, invasion, and axillary metastasis in ductal carcinoma in situ.
    Maffuz A; Barroso-Bravo S; Nájera I; Zarco G; Alvarado-Cabrero I; Rodríguez-Cuevas SA
    J Exp Clin Cancer Res; 2006 Jun; 25(2):223-7. PubMed ID: 16918134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors predicting microinvasion in Ductal Carcinoma in situ.
    Ozkan-Gurdal S; Cabioglu N; Ozcinar B; Muslumanoglu M; Ozmen V; Kecer M; Yavuz E; Igci A
    Asian Pac J Cancer Prev; 2014; 15(1):55-60. PubMed ID: 24528005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymph node biopsy in patients affected by breast ductal carcinoma in situ with and without microinvasion: Retrospective observational study.
    Bertozzi S; Cedolini C; Londero AP; Baita B; Giacomuzzi F; Capobianco D; Tortelli M; Uzzau A; Mariuzzi L; Risaliti A
    Medicine (Baltimore); 2019 Jan; 98(1):e13831. PubMed ID: 30608397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of breast ductal carcinoma in situ and ductal carcinoma in situ with microinvasion, and analysis of axillary lymph node metastasis.
    Zhang G; Li C; Tian G; Cheng X; Li Y; Ma L
    Medicine (Baltimore); 2020 Dec; 99(52):e23593. PubMed ID: 33350734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axillary staging in ductal carcinoma in situ with microinvasion: A meta-analysis.
    Choi B; Jegatheeswaran L; Nakhoul M; Haria P; Srivastava R; Karki S; Lupi M; Patel V; Chakravorty A; Babu E
    Surg Oncol; 2021 Jun; 37():101557. PubMed ID: 33819852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors of axillary positive sentinel lymph node biopsy in extended ductal carcinoma in situ treated by simple mastectomy at once.
    Hotton J; Salleron J; Rauch P; Buhler J; Pierret M; Baumard F; Leufflen L; Marchal F
    J Gynecol Obstet Hum Reprod; 2020 Mar; 49(3):101641. PubMed ID: 31562936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph node metastasis from ductal carcinoma in situ with microinvasion.
    Zavotsky J; Hansen N; Brennan MB; Turner RR; Giuliano AE
    Cancer; 1999 Jun; 85(11):2439-43. PubMed ID: 10357415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymph node metastasis in microinvasive breast cancer.
    Intra M; Zurrida S; Maffini F; Sonzogni A; Trifirò G; Gennari R; Arnone P; Bassani G; Opazo A; Paganelli G; Viale G; Veronesi U
    Ann Surg Oncol; 2003 Dec; 10(10):1160-5. PubMed ID: 14654471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of intraoperative frozen section examination of sentinel lymph nodes in ductal carcinoma in situ of the breast.
    Ballehaninna UK; Chamberlain RS
    Clin Breast Cancer; 2013 Oct; 13(5):350-8. PubMed ID: 23791128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ductal Carcinoma In Situ with Microinvasion on Core Biopsy: Evaluating Tumor Upstaging Rate, Lymph Node Metastasis Rate, and Associated Predictive Variables.
    Phantana-Angkool A; Voci AE; Warren YE; Livasy CA; Beasley LM; Robinson MM; Hadzikadic-Gusic L; Sarantou T; Forster MR; Sarma D; White RL
    Ann Surg Oncol; 2019 Nov; 26(12):3874-3882. PubMed ID: 31342378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.